Laboratory Analytical Instruments · SIC 3826

Nautilus Biotechnology, Inc.

NAUT

Watch

Latest revenue

as of

Latest net income

as of

Net margin

as of

Price · 5Y

-24.9% / yr 38.6 pts / yr vs S&P 500 75.7% total
Compare:

Live market

delayed ≤15 min
$2.54
0.00%
Market cap
$322.8M
Enterprise value
$322.8M
P/E (trailing)
Forward P/E
P/B
Dividend yield
0.0%
52-wk high
$4.31
52-wk low
$0.62
Beta
Shares out
127.1M

5-year trend

What this company does

AI

Item 1. Business BACKGROUND OF BUSINESS COMBINATION On June 9, 2021 (the “Closing Date”), Nautilus Biotechnology, Inc., a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp III (“ARYA”)), consummated the business combination (the “Business Combination”) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the “Business Combination Agreement”), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (“Mako Merger Sub”), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (“Legacy Nautilus”). The Business Combination Agreement provided for, among other…

AI summary unavailable — showing raw filing excerpt

Generated from NAUT's filing dated 2026-02-26

Key risks

AI

Item 1A. Risk Factors You should consider carefully the following information about the risks described below, together with the other information contained in this Annual Report on Form 10-K and in our other public filings, in evaluating our business. If any of the following risks actually occurs, our business, financial condition, results of operations, and future growth prospects would likely be materially and adversely affected. In these circumstances, the market price of our common stock would likely decline. Summary Risk Factors Our business is subject to numerous risks and uncertainties that you should consider before investing in our company, as more fully described below. The…

AI summary unavailable — showing raw filing excerpt

Generated from NAUT's filing dated 2026-02-26

Profitability

Return on equity

-28.3%

6.0%

Return on assets

-30.9%

5.9%

Leverage

Debt / equity

-0.08×

0.9%

Debt / assets

-9.2%

1.0%

Earnings tracker

QuarterRevenueYoYNet incomeYoYNet margin

Q1 2026

2026-03-31

$-14.7M+11.5%

Q4 2025

2025-12-31

$-13.8M+21.7%

Q3 2025

2025-09-30

$-13.6M+17.5%

Q2 2025

2025-06-30

$-15.0M+16.5%

Q1 2025

2025-03-31

$-16.6M+11.3%

Q4 2024

2024-12-31

$-17.6M

Q3 2024

2024-09-30

$-16.4M-3.6%

Q2 2024

2024-06-30

$-18.0M-13.9%

Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.

Industry trend

Laboratory Analytical Instruments · SIC 3826

Your notes

Keep private notes on NAUT — thesis, target price, catalysts to watch.

Visible only to you. Never shared. Never used to train AI.

Sign in to write a note

Insider activity

Insider buying

$231.1K

Insider selling

$0

Net activity

+$231.1K

Distinct insiders

4

Open-market trades over the last 365 days.

Recent transactions

DateInsiderTypeSharesPriceValue
2026-03-04

Sujal M Patel

CEO, President, and Secretary

Purchase25,000$2.61$65.2K
2025-11-06

Kentaro Suzuki

Chief Marketing Officer

Purchase4,000$1.49$6.0K
2025-09-08

Sujal M Patel

CEO, President, and Secretary

Purchase83,500$0.68$57.0K
2025-09-05

Sujal M Patel

CEO, President, and Secretary

Purchase116,500$0.67$78.5K
2025-09-04

Matthew B. Murphy

General Counsel

Purchase20,000$0.64$12.9K
2025-05-29

Anna Mowry

CFO and Treasurer

Purchase15,000$0.77$11.5K

Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.

Who owns NAUT

Institutional value

$59.4M

Total shares held

17.0M

Distinct holders

42

-26 vs prior

As of

2026-03-31

Prior: 2025-12-31

Filers with $100M+ AUM disclose holdings 45 days after quarter end.

Top institutional holders

#ManagerSharesValueQoQ changeAction
1Cercano Management LLC7.2M$27.8M+0 (+0.0%)No change
2VANGUARD CAPITAL MANAGEMENT LLC2.5M$9.9MNew
3Clearstead Advisors, LLC2.3M$9.0MNew
4AMAZON COM INC1.5M$5.7M+0 (+0.0%)No change
5DIMENSIONAL FUND ADVISORS LP329.1K$1.3M+43.7K (+15.3%)Added
6VANGUARD FIDUCIARY TRUST CO305.5K$1.2MNew
7HILLMAN CO200.0K$776.0K+0 (+0.0%)No change
8BlackRock, Inc.187.7K$728.2K-1.8K (-0.9%)Trimmed
9Crewe Advisors LLC136.1K$527.9K+0 (+0.0%)No change
10Palumbo Wealth Management LLC65.2K$253.1K+24.1K (+58.6%)Added
11JANE STREET GROUP, LLC61.8K$239.8K-145.0K (-70.1%)Trimmed
12CITIZENS FINANCIAL GROUP INC/RI50.0K$194.0KNew
13HSBC HOLDINGS PLC49.4K$189.9K-49.4K (-50.0%)Trimmed
14Catalyst Funds Management Pty Ltd46.3K$179.8KNew
15Ashton Thomas Private Wealth, LLC45.0K$174.6K+0 (+0.0%)No change
16Caprock Group, LLC44.1K$171.1K+0 (+0.0%)No change
17SEI INVESTMENTS CO38.6K$149.9KNew
18Presidio Capital Management, LLC34.7K$134.5K+0 (+0.0%)No change
19Badgley Phelps Wealth Managers, LLC30.0K$116.4K+0 (+0.0%)No change
20Hudson Bay Capital Management LP29.6K$114.8K+10.5K (+55.3%)Added

Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.

Top questions investors are asking

Coming once NAUT's latest filing finishes processing.